Published in Int J Cancer on October 01, 1994
Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev (2009) 9.60
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996. Environ Health Perspect (2000) 2.71
House dust concentrations of organophosphate flame retardants in relation to hormone levels and semen quality parameters. Environ Health Perspect (2010) 2.52
Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. BMJ (1996) 2.31
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect (1998) 1.90
Risk of testicular cancer in subfertile men: case-control study. BMJ (1999) 1.77
Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ (2000) 1.73
Scrotal temperature is increased in disposable plastic lined nappies. Arch Dis Child (2000) 1.67
Developmental exposure to low dose PBDE 99: effects on male fertility and neurobehavior in rat offspring. Environ Health Perspect (2005) 1.63
Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect (1998) 1.60
Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev (2001) 1.49
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl (2008) 1.31
Exposure to pesticides and cryptorchidism: geographical evidence of a possible association. Environ Health Perspect (1996) 1.26
Decreasing sperm quality: a global problem? BMC Public Health (2010) 1.15
Are problems with male reproductive health caused by endocrine disruption? Occup Environ Med (2001) 1.04
Long-term effects of environmental endocrine disruptors on reproductive physiology and behavior. Front Behav Neurosci (2009) 1.04
Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer (2005) 1.03
Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ Health Perspect (2000) 1.03
Male infertility: a risk factor for testicular cancer. Nat Rev Urol (2009) 1.02
Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer (2002) 1.01
Impaired reproductive development in sons of women occupationally exposed to pesticides during pregnancy. Environ Health Perspect (2008) 1.01
Testicular cancer risk and maternal parity: a population-based cohort study. Br J Cancer (1998) 0.99
Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation. Proc Natl Acad Sci U S A (2007) 0.96
Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays. Environ Health Perspect (1998) 0.96
Plant-associated bacterial degradation of toxic organic compounds in soil. Int J Environ Res Public Health (2009) 0.96
Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95
Effect of neonatal exposure to estrogenic compounds on development of the excurrent ducts of the rat testis through puberty to adulthood. Environ Health Perspect (1999) 0.93
Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells. Neoplasia (2006) 0.90
Testicular cancer and HPV semen infection. Front Endocrinol (Lausanne) (2012) 0.90
Testicular cancer: seminoma. BMJ Clin Evid (2007) 0.88
Geographic clustering of testicular cancer incidence in the northern part of The Netherlands. Br J Cancer (1999) 0.87
Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer (2001) 0.86
Childhood cancer in the offspring of male sawmill workers occupationally exposed to chlorophenate fungicides. Environ Health Perspect (2000) 0.85
Involvement of dysadherin and E-cadherin in the development of testicular tumours. Br J Cancer (2005) 0.85
Multiple structural and functional abnormalities in the p450 aromatase expressing transgenic male mice are ameliorated by a p450 aromatase inhibitor. Am J Pathol (2004) 0.84
Changes in semen and the testis. BMJ (1994) 0.83
Survival from testicular cancer in England and Wales up to 2001. Br J Cancer (2008) 0.82
Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology (2014) 0.81
Semen quality of 1559 young men from four cities in Japan: a cross-sectional population-based study. BMJ Open (2013) 0.80
Environmental factors influencing public health and medicine: policy implications. J Natl Med Assoc (2002) 0.80
Testicular cancer: seminoma. BMJ Clin Evid (2011) 0.80
[Molecular pathology of testicular germ cell tumors: an update]. Pathologe (2008) 0.78
Characterization of the model for experimental testicular teratoma in 129/SvJ-mice. Br J Cancer (1999) 0.78
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease. BMC Cancer (2016) 0.77
Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. BMC Res Notes (2016) 0.77
The participation of prospective fathers in preconception care. Clin Med Insights Reprod Health (2013) 0.76
Testicular cancer and infertility. BMJ (2000) 0.76
Blood levels of polychlorinated biphenlys and organochlorinated pesticides in women from Istanbul, Turkey. Environ Monit Assess (2015) 0.76
A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. Oncotarget (2016) 0.75
Use of cancer incidence data in identification of cancer causation. Environ Health Perspect (1996) 0.75
The histologic features of intratubular germ cell neoplasia and its correlation with tumor behavior. Investig Clin Urol (2016) 0.75
Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol (2017) 0.75
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026. Cancer (2017) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (1997) 5.37
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry (2001) 4.15
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Stressful life events and Graves' disease. Lancet (1991) 3.63
Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther (2012) 3.57
Sickness in pregnancy and sex of child. Lancet (1999) 3.48
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Appendectomy and protection against ulcerative colitis. N Engl J Med (2001) 3.06
Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control (1996) 3.01
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis (2005) 2.93
Adenylate Levels, Energy Charge, and Phosphorylation Potential during Dark-Light and Light-Dark Transition in Chloroplasts, Mitochondria, and Cytosol of Mesophyll Protoplasts from Avena sativa L. Plant Physiol (1982) 2.92
Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet (1994) 2.83
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
The impact of endoscopists' experience and learning curves and interendoscopist variation on colonoscopy completion rates. Endoscopy (2001) 2.55
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ (1998) 2.51
Xylem-tapping mistletoes: water or nutrient parasites? Science (1985) 2.49
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Patient delay and stage of diagnosis among breast cancer patients in Germany -- a population based study. Br J Cancer (2002) 2.34
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther (2000) 2.25
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control (2000) 2.24
Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med (2008) 2.21
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut (1998) 2.14
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
High birthweight as a predictor of prostate cancer risk. Epidemiology (1995) 2.12
Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county. J Epidemiol Community Health (1982) 2.11
Cancer mortality among man-made vitreous fiber production workers. Epidemiology (1997) 2.10
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Cancer risk among patients with multiple sclerosis and their parents. Neurology (2009) 2.03
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Risk factors for pulmonary tuberculosis in Estonia. Int J Tuberc Lung Dis (2002) 1.92
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr (2000) 1.90
Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87
Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer (2003) 1.87
Observed and relative survival after aortic valve replacement. J Am Coll Cardiol (2000) 1.86
Patterns of cigarette sales and lung cancer mortality in some central and eastern European countries, 1960-1989. Cancer (1995) 1.86
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Coeliac disease and risk of sepsis. Gut (2008) 1.86
Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer (1997) 1.84
Non-neoplastic mortality of European workers who produce man made vitreous fibres. Occup Environ Med (1999) 1.83
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million Norwegian women. Epidemiology (1994) 1.81
Surgical anatomy of human parathyroid glands. Surgery (1984) 1.81
Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer (2006) 1.80
Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut (1999) 1.79
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ (2000) 1.77
Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999) 1.76
Familial testicular cancer in Norway and southern Sweden. Br J Cancer (1996) 1.76
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut (2005) 1.75
Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer (1993) 1.75
Biochemical aspects of phloem transport. Symp Soc Exp Biol (1974) 1.75
Incidence of childhood cancer in Finland. J Natl Cancer Inst (1975) 1.73
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet (2001) 1.72
Complications of diagnostic and therapeutic colonoscopy within a defined population in Sweden. Gastrointest Endosc (2001) 1.71
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med (2010) 1.71
Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut (2005) 1.70